biotech
biotech Articles
ThinkstockShares of Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) sank on Monday after the company announced that there will be an interruption in the supply of Auryxia (ferric citrate) tablets due...
Published:
Finally, concerns about biotech seem to be waning. An RBC research report notes that at the recent political conventions there was little to no mention of drug pricing.
Published:
Last Updated:
Shares of Biogen and, especially, Ionis Pharmaceuticals made handy gains early Monday morning following favorable interim results from a late-stage trial.
Published:
Last Updated:
Gilead Sciences reported its earnings on Monday of last week, and since that time there has been much analyst activity around the stock.
Published:
Last Updated:
These three biotech companies not only have data that could prove to be huge, but they have been absolutely hammered over the last year and are offering aggressive accounts the best entry points in...
Published:
Last Updated:
The recent performance from Gilead Sciences has analysts and investors concerned about the future. Argus believes that the headwinds are blowing harder than the tailwinds for the company.
Published:
Last Updated:
Shares of Seres Therapeutics took an absolute dive early in Friday’s session as the company stared down the barrel of a seemingly failed mid-stage clinical trial.
Published:
Last Updated:
Overall, investors were content after Celgene reported its second-quarter financial results, with wins on both the top and bottom lines.
Published:
Last Updated:
Amgen is expected to report its second-quarter financial results after the markets close on Wednesday. Will it go the same way as Gilead Sciences did earlier this week?
Published:
Last Updated:
A new JPMorgan research report says it time to buy the health care sector and sell consumer staples, which have run hard this year.
Published:
Last Updated:
The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected biotech stocks.
Published:
Last Updated:
Although Gilead Sciences is one of the world’s leading biotech companies, an earnings beat in its latest report was not enough to satisfy investors.
Published:
Last Updated:
Gilead Sciences is scheduled to release its second-quarter financial results after the markets close on Monday.
Published:
Last Updated:
Puma Biotechnology watched its shares make a handy gain on Friday morning after the firm released updated results from its late-stage breast cancer trial.
Published:
Last Updated:
Relypsa made a splash in the markets on Thursday morning after the company announced an acquisition agreement.
Published:
Last Updated: